Codes ATC:
C09DB04
Indication
Essential hypertension
Code ICD11:
BA00.Z
INN
Telmisartan + amlodipine
Type de médicament
Chemical agent
Type de liste
Liste de base
Formulations
Oral > Solid:
40 mg + 5 mg ;
80 mg + 5 mg ;
80 mg + 10 mg
Historique des statuts LME
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
Des médicaments appartenant à la même classe pharmacologique peuvent être utilisés
Limites de l'équivalence thérapeutique
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup C09CA Angiotensin II receptor blockers (ARBs), plain (for telmisartan); and C08CA Dihydropyridine derivatives (for amlodipine)
Renseignements sur le brevet
Main patents have expired but secondary patents might remain active in some jurisdictions. For more
information on specific patents and license status for developing countries visit www.MedsPal.org
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that fixed-dose combinations of medicines in 4th level ATC chemical subgroups, C09CA Angiotensin II receptor blockers (ARBs), plain (for telmisartan); and C08CA Dihydropyridine derivatives (for amlodipine), be specified as therapeutic alternatives under the square box listing for telmisartan + amlodipine on the EML.